Source: Global Times New Media
The US Bloomberg said on May 6 that in the face of the epidemic, after India and the United States "dropped the chain", the world is turning to China for the new crown vaccine .
The article said that Although the United States is trying to shape itself into a broader supplier of vaccines, India's fast-spreading epidemic has stifled its ability to fulfill supply agreements, and the world is increasingly reliant on vaccines produced in China.
China has distributed hundreds of millions of vaccines to the world
In the past few weeks, despite concerns about the effectiveness of China's vaccine, leaders of some of the world's most populous countries have turned to China for more opportunities. This demand will increase further if the World Health Organization approves China's Sinopharm and Sinopharm vaccines as expected, thereby allowing developing countries in Asia, Africa and Latin America to obtain vaccines through the global vaccine program Covax.
According to the latest news, the World Health Organization announced on the 7th that the new crown inactivated vaccine developed by the China Pharmaceutical Group Beijing Institute of Biological Products has officially passed the WHO emergency use certification. In addition, independent experts from the WHO Strategic Advisory Group of Experts (SAGE) evaluated Sinovac vaccination in Phase 3 clinical trials conducted in China, Brazil, Indonesia, Turkey and Chile. SAGE experts said that Sinovac vaccines have been authorized in 32 countries and regions, and more than 260 million doses of vaccines have been distributed. SAGE published its assessment on the WHO website: "We are very confident that two doses of Sinovac vaccine are effective in preventing -COVID-19 in adults (18 to 59 years old).
US media said that after the successful approval of the Chinese vaccine, it will strengthen the Covax vaccination program supported by WHO, which had previously relied heavily on the vaccine production capacity of the Serum Institute of India.
Due to the severe domestic epidemic, India's vaccine exports have been hit hard "China is not just the largest exporter of vaccines, for many countries, Chinese vaccines have become their only option. "Huang Yanzhong, a health expert and senior fellow for global health at the Council on Foreign Relations in the United States, said.
China's profit in this situation seems to make Bloomberg very worried. The American media said that due to the global pandemic response of the United States and the European Union to the new crown epidemic Slowly, the outbreaks in Brazil and India are out of control, and China's reliability as a vaccine supplier is increasing its geopolitical clout. Further "complicating" the situation is that the domestic new crown crisis in India has dried up vaccine supplies, prompting many The country has turned to China. Against this backdrop, Bloomberg said the U.S. has been focusing only on domestic vaccinations for months and hoarding vaccines at the expense of global responsibility, which has also drawn strong criticism from the United States.
US President Biden Data map
However, US President Biden made it clear this week that the United States intends to start playing a more active role. On Wednesday, the United States expressed support for the move to abandon the new crown vaccine patent to allow other countries to produce. Biden vows The U.S. will be globally a "weapon against coronavirus " as outbreaks elsewhere in the world could create dangerous mutated viruses that could prolong the crisis. To date, US government efforts include plans to provide 60 million Dosing AstraZeneca vaccine, and increase the production of Moderna, Pfizer, Johnson & Johnson vaccine.
But at the same time, from Uruguay to Senegal to Indonesia, these countries have no choice but China in terms of vaccine supply. China has exported about 240 million doses of the vaccine, more than all other countries combined, and has pledged to deliver another 500 million, according to scientific information and analytics firm Airfinity Ltd. India is the world's third-largest supplier of vaccines after China and the European Union. India had exported 67 million doses to nearly 100 countries until the devastating outbreak prompted the country to halt most deliveries in recent weeks.
Covax has shipped more than 50 million doses to 121 countries and territories, but has fallen far short of its goal and is only one-fifth of its domestic distribution in the United States. A new deal with Moderna expands Covax's supply of doses, but will only deliver a fraction of its promised 500 million doses this year.
WHO's authorization of vaccines in China may bring the most direct help to governments that are ready to provide vaccines to their own people and are only short of approval. For example, so far, Sri Lanka has obtained 600,000 Chinese medicine vaccines, but less than 1% of them have been used, and they have been used on Chinese workers in the country. As
wrote here, the US media began to hack the Chinese vaccine again, saying some experts were concerned about the "potential impact on public health" of widespread use of the Chinese vaccine, which is "less effective than Pfizer and Moderna." ". Nicholas Thomas, an associate professor at City University of Hong Kong interviewed by
Bloomberg, also said: "In the medium term, WHO's approval of China's vaccine will help strengthen China's strength and authority in the region. However, the effectiveness of China's vaccine So long as Western countries can increase their own supply, they can easily compete with China.”
Bloomberg also claimed that it is precisely for this reason that China will desperately seize the opportunity during this time period to promote its own vaccine to various countries. Chinese officials have also been aggressively marketing their vaccines to neighboring countries for some time.
However, China's Ministry of Foreign Affairs previously stated in response to a question about the effectiveness of China's vaccines that the Chinese government has always put the safety and effectiveness of the new crown vaccine first. Chinese vaccine R&D companies have always promoted vaccine R&D in strict accordance with scientific laws and regulatory requirements. Relevant data that have been published also show that the effectiveness of China's vaccines meets the standards of the World Health Organization.
